A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.

Saved in:
Bibliographic Details
Title: A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
Authors: Rambaldi A; Haematology, Ospedali Riuniti Di Bergamo, Largo Barozzi, Bergamo, Italy. arambaldi@ospedaliriuniti.bergamo.it, Dellacasa CM, Finazzi G, Carobbio A, Ferrari ML, Guglielmelli P, Gattoni E, Salmoiraghi S, Finazzi MC, Di Tollo S, D'Urzo C, Vannucchi AM, Barosi G, Barbui T
Source: British journal of haematology [Br J Haematol] 2010 Aug; Vol. 150 (4), pp. 446-55. Date of Electronic Publication: 2010 Jun 15.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2141
DOI:10.1111/j.1365-2141.2010.08266.x